Impact of residual plaque burden on clinical outcomes of coronary interventions

Y Honda1, P G Yock, P J Fitzgerald

  • 1Center for Research in Cardiovascular Interventions, Stanford University Medical Center, California 94305, USA.

Insights

Residual plaque burden, measured by intravascular ultrasound, predicts restenosis after percutaneous coronary interventions. Minimizing plaque burden may improve outcomes with stenting and debulking therapies.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Percutaneous coronary interventions (PCI) aim to restore coronary blood flow.
  • Restenosis, or re-narrowing of the artery, remains a significant complication after PCI.
  • Residual plaque burden is increasingly recognized as a key factor influencing restenosis.

Purpose of the Study:

  • To summarize the role of residual plaque burden in restenosis development post-PCI.
  • To explore how intravascular ultrasound (IVUS) assessment of plaque impacts restenosis prediction.
  • To evaluate the influence of plaque burden on outcomes with different PCI techniques, including stenting and debulking.

Main Methods:

  • Review of clinical trials and evidence on residual plaque burden and restenosis.
  • Analysis of intravascular ultrasound (IVUS) data for plaque quantification.
  • Examination of the interaction between plaque burden, vessel remodeling, and PCI outcomes.

Main Results:

  • Residual plaque burden is a consistent and independent predictor of restenosis after PCI.
  • Negative vessel remodeling exacerbates the impact of plaque burden on late lumen loss, especially after balloon angioplasty and atherectomy.
  • Evidence suggests plaque burden is also critical in stenting, with debulking potentially enhancing long-term outcomes.

Conclusions:

  • Intravascular ultrasound (IVUS) assessment of residual plaque burden can aid in risk stratification.
  • Optimizing plaque removal and managing vessel response are crucial for preventing restenosis.
  • Further research into debulking strategies alongside stenting may improve long-term PCI success rates.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...